Conclusion of a non-exclusive rebate agreement under Section 130a(8) of the German Social Code Book V for the active substance Bexarotene, ATC L01XF03, for the period 01/06/2026–31/05/2028 (plus option to extend once by 12 months)

Summary

The tender concerns a non-exclusive rebate agreement for medicines containing the active substance Bexarotene (ATC L01XF03) for DAK-Gesundheit. The aim is to allow interested pharmaceutical companies to join on the same terms during the period 01/06/2026–31/05/2028, with one possible extension of 12 months. The bidder must submit the required contract documents by email and should check the tender documents for the exact requirements.